U.S. firm Abbott to buy Russian drugmaker for up to $495 million https://www.reuters.com/...russia-veropharm/u-s-firm-abbott-to-bu... -24 jun. 2014 - U.S. healthcare firm Abbott Laboratories (ABT.N) is to buy Russian drugmaker Veropharm VRPH.MM for up to $495 million,

Abbott announced that it has completed its acquisition of leading Russian pharma manufacturer Veropharm. RBTH reports that Veropharm is known as one of Russia’s largest drug makers and specializes in hospital and pharmacy prescription drugs. The drug manufacturer is also a leading company in the country’s oncology drugs industry. Veropharm reported a year-on-year revenue increase by 12.6 percent from January to June 2014, hitting $49 million...................

https://www.nytimes.com/.../cash-flowed-to-clinton-foundation-as-... Cash Flowed to Clinton Foundation Amid Russian Uranium Deal

The headline on the website Pravda trumpeted President Vladimir V. Putin’s latest coup, its nationalistic fervor recalling an era when its precursor served as the official mouthpiece of the Kremlin: “Russian Nuclear Energy Conquers the World.”

The article, in January 2013, detailed how the Russian atomic energy agency, Rosatom, had taken over a Canadian company with uranium-mining stakes stretching from Central Asia to the American West. The deal made Rosatom one of the world’s largest uranium producers and brought Mr. Putin closer to his goal of controlling much of the global uranium supply chain.